145 related articles for article (PubMed ID: 15619744)
1. Management of cutaneous melanoma.
Miranda EP
N Engl J Med; 2004 Dec; 351(26):2770-1; author reply 2770-1. PubMed ID: 15619744
[No Abstract] [Full Text] [Related]
2. Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in sentinel lymph node-positive melanoma.
Miranda EP
J Clin Oncol; 2006 Nov; 24(32):5178; author reply 5178. PubMed ID: 17093288
[No Abstract] [Full Text] [Related]
3. Multimethod imaging, staging, and spectrum of manifestations of metastatic melanoma.
Patnana M; Bronstein Y; Szklaruk J; Bedi DG; Hwu WJ; Gershenwald JE; Prieto VG; Ng CS
Clin Radiol; 2011 Mar; 66(3):224-36. PubMed ID: 21295201
[TBL] [Abstract][Full Text] [Related]
4. Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma.
Pfannenberg C; Aschoff P; Schanz S; Eschmann SM; Plathow C; Eigentler TK; Garbe C; Brechtel K; Vonthein R; Bares R; Claussen CD; Schlemmer HP
Eur J Cancer; 2007 Feb; 43(3):557-64. PubMed ID: 17224266
[TBL] [Abstract][Full Text] [Related]
5. Update on diagnostic imaging for melanoma.
Grasee EA; Wagner JD
Facial Plast Surg Clin North Am; 2003 Feb; 11(1):49-60. PubMed ID: 15062287
[No Abstract] [Full Text] [Related]
6. Hypermetabolic dermatofibroma on Positron Emission Tomography/Computed tomography with 18F-FluoroDeoxyGlucose : a misleading false positive in the follow-up of a metastatic melanoma.
Battistella M; Trabelsi S; Terrier-Lacombe MJ; Leboulleux S; Robert C
Eur J Dermatol; 2008; 18(4):461-2. PubMed ID: 18573725
[No Abstract] [Full Text] [Related]
7. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.
Nomori H; Mori T; Ikeda K; Kawanaka K; Shiraishi S; Katahira K; Yamashita Y
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):816-22. PubMed ID: 18374761
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous melanoma: baseline and ongoing laboratory evaluation.
Garbe C
Dermatol Ther; 2005; 18(6):413-21. PubMed ID: 16297017
[TBL] [Abstract][Full Text] [Related]
9. Novel imaging techniques in melanoma.
Essner R; Belhocine T; Scott AM; Even-Sapir E
Surg Oncol Clin N Am; 2006 Apr; 15(2):253-83. PubMed ID: 16632214
[TBL] [Abstract][Full Text] [Related]
10. Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma.
Aloia TA; Gershenwald JE; Andtbacka RH; Johnson MM; Schacherer CW; Ng CS; Cormier JN; Lee JE; Ross MI; Mansfield PF
J Clin Oncol; 2006 Jun; 24(18):2858-65. PubMed ID: 16782925
[TBL] [Abstract][Full Text] [Related]
11. Use of Preoperative PET/CT Staging in Sentinel Lymph Node-Positive Melanoma.
Scheier BY; Lao CD; Kidwell KM; Redman BG
JAMA Oncol; 2016 Jan; 2(1):136-7. PubMed ID: 26401901
[No Abstract] [Full Text] [Related]
12. Imaging in cutaneous melanoma.
Ho Shon IA; Chung DK; Saw RP; Thompson JF
Nucl Med Commun; 2008 Oct; 29(10):847-76. PubMed ID: 18769303
[TBL] [Abstract][Full Text] [Related]
13. Imaging studies in patients with melanoma.
Choi EA; Gershenwald JE
Surg Oncol Clin N Am; 2007 Apr; 16(2):403-30. PubMed ID: 17560520
[TBL] [Abstract][Full Text] [Related]
14. [The latest diagnostical methods and therapy in melanoma].
Wojas-Pelc A; Rajzer L; Jaworek A; Woźniak W
Przegl Lek; 2006; 63(8):674-80. PubMed ID: 17441381
[TBL] [Abstract][Full Text] [Related]
15. Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma.
Müller-Horvat C; Radny P; Eigentler TK; Schäfer J; Pfannenberg C; Horger M; Khorchidi S; Nägele T; Garbe C; Claussen CD; Schlemmer HP
Eur J Cancer; 2006 Feb; 42(3):342-50. PubMed ID: 16364631
[TBL] [Abstract][Full Text] [Related]
16. Imaging of metastatic melanoma.
King DM
Cancer Imaging; 2006 Dec; 6(1):204-8. PubMed ID: 17208677
[TBL] [Abstract][Full Text] [Related]
17. Interpretation, accuracy and management implications of FDG PET/CT in cutaneous malignant melanoma.
Falk MS; Truitt AK; Coakley FV; Kashani-Sabet M; Hawkins RA; Franc B
Nucl Med Commun; 2007 Apr; 28(4):273-80. PubMed ID: 17325590
[TBL] [Abstract][Full Text] [Related]
18. [Use of fluorine-18-FDG PET-CT scans in initial management and follow-up of patients with cutaneous melanoma].
Sarandi F; Hindié E; Kerob D; Basset-Seguin N; Lebbé C; Toubert ME; Filmont JE; Groheux D; Teyton P; Moretti JL
Ann Dermatol Venereol; 2008 Oct; 135(10):691-9. PubMed ID: 18929924
[No Abstract] [Full Text] [Related]
19. Sentinel lymph node biopsy as the standard of care for cutaneous melanoma.
Sondak VK; Zager JS; Messina JL; Thomas JM
Clin Adv Hematol Oncol; 2007 Jun; 5(6):483-90. PubMed ID: 17679922
[No Abstract] [Full Text] [Related]
20. Preoperative imaging for early-stage cutaneous melanoma: predictors, usage, and utility at a single institution.
Haddad D; Garvey EM; Mihalik L; Pockaj BA; Gray RJ; Wasif N
Am J Surg; 2013 Dec; 206(6):979-85; discussion 985-6. PubMed ID: 24124660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
